Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries
Condition(s) studied
Investigational drug(s) / intervention(s)
Vastus lateralis nerve block: Patients received vastus lateralis nerve block with 5 ml of bupivacaine 0.5%.
Lateral femoral cutaneous nerve block: Patients received lateral femoral cutaneous nerve block with 5 ml of bupivacaine 0.5%.
Study summary
This study aims to compare the analgesic efficacy and functional outcomes of blocking the nerve to the vastus lateralis (NVL) muscle versus the lateral femoral cutaneous nerve (LFCN).
Eligibility
Primary outcome measure(s)
- Degree of pain — 24 hours postoperatively
Each patient will be instructed about postoperative pain assessment using the numeric rating scale (NRS) score (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS assessments will be conducted at the post-anesthesia care unit (PACU) and at 2, 4, 6, 12, 18, and 24 hours postoperatively.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Kafrelsheikh University | Kafr ash Shaykh | Kafrelsheikh | Recruiting |
More Kafrelsheikh University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06809842 on ClinicalTrials.gov ↗ ← All trials in Egypt